COVID-19 vaccinations are being distributed and administered across the U.S., and right here in the Capital Region. The vaccine is completely free to all patients.
COVID-19 Mobile Vaccine Clinic
CDPHP, the Albany County Department of Health, and FOCUS Churches of Albany, will be holding the following mobile vaccine clinics:
Friday, May 14 and Friday, May 21 (10 a.m. – 1 p.m)
Emmanuel Baptist Church
275 State Street, Albany (directions)
No registration is required. You must be at least 16 years old to receive the vaccine. A first dose of the Pfizer vaccine will be given. A second dose will be scheduled at the time of your appointment.
Am I eligible for a vaccine?
If you would like to see if you’re eligible to receive a COVID-19 vaccine, head to the state’s Am I Eligible website. For more information, please contact your physician or pharmacist.
Additional information regarding the vaccines is as follows:
-
The Johnson & Johnson vaccine requires only 1 dose; Moderna and Pfizer require 2 doses 4 weeks and 3 weeks apart, respectively.
-
The Pfizer vaccine is licensed for age 12 and older; the other two vaccines, Moderna and Johnson & Johnson, are licensed for age 18 and older.
-
CDPHP strongly encourages all eligible members to get the COVID-19 vaccine, and continues urging all members to get a flu shot.
-
Medicare members: Please remember to bring your red, white, and blue Medicare card to your vaccine appointment.
An Important Note about Medicare Advantage
For Medicare Advantage members, the cost of the vaccine and the administration of it will be covered under Original Medicare. When you receive your vaccination, you may see on your Explanation of Benefits (EOB) “Bill to Medicare FFS – Member not Liable.” Please note that you are not responsible for this cost. Your provider will know to bill Medicare directly. CDPHP is educating providers on this process, but if your doctor or pharmacy has any questions, they may contact CDPHP provider services for help.
COVID-19 Antibody Treatment
The Food and Drug Administration (FDA) has issued an emergency use authorization for antibody treatment of mild to moderate COVID-19 in adults and pediatric patients (12 and older) who are at high-risk for progressing to severe COVID-19. This includes those who are 65 and older, or those with certain chronic medical conditions. If you have been diagnosed with COVID-19, talk to your health care provider about whether this is an appropriate course of treatment.